The Cressa Clinic
Fast-tracking your
mission to remission
Specialist rheumatology, whole-person care and continuous monitoring, delivered from the comfort of your own home.
Check eligibilityEarly detection
The same flare.
Two very different outcomes.
Most autoimmune flares escalate because no one is watching. Cressa’s remote early detection system and multidisciplinary care team catch the signal early and act before it becomes a crisis.
Without Cressa
Reactive care, untimely escalation, avoidable crisis. Fixed appointments every six months with no one there in between.
With Cressa
Remote, continuous care that responds early, armed with real health data. Changes are detected early, the plan is adjusted, and the crisis is avoided.
For patients
A virtual care team
built around you
Inflammatory conditions affect so much more than your joints. Cressa wraps a virtual care team around you, builds a treatment plan that works, and adapts it quickly when things change.
Monitoring system built on symptoms reporting, smartwatch health data and at-home blood tests
In-network with most major insurers
Monthly intelligence, keeping you on target
Daily holistic self-management
How it works
- STEP 1
Understand your unique disease
Connect your wearable, complete our questionnaire, and receive a personalized at-home blood panel, so we understand your disease before we build your plan.
- STEP 2
Agree on your remission plan
Your rheumatologist and health coach build a personalized treatment plan to guide you toward remission, with monthly input and intelligence reports to track progress.
- STEP 3
Holistic day-to-day support
Track symptoms, spot new insights, manage medications, get real-time personalized pacing support and engage your care team via the Cressa app.
- STEP 4
Specialists in the loop
At-home blood tests and follow-up calls when your nurse spots early signs of deterioration, escalated to your specialist rheumatologist to triage appropriately.
A team of specialists that meets you where you are
- ED
Emma Dyson
Chief Medical Officer
An award-winning clinician and co-founder of Cressa, with deep expertise in clinical research, regulation and digital health. Emma makes sure every part of Cressa’s care model is evidence-based, safe and clinically meaningful.
Erin Hammett, DO
Medical Director
Triple board-certified in rheumatology, internal medicine and lifestyle medicine. More than a decade treating complex autoimmune disease, pairing evidence-based treatment with nutrition and lifestyle care.
Amy Behimer, PharmD, NBC-HWC
Health Coach
A pharmacist turned board-certified health coach who lives well with multiple sclerosis. Amy helps patients build the daily habits that make treatment work.
For referring physicians
Get your patients seen by a specialist in <2 weeks
Rheumatology wait times are measured in months. Cressa gets your autoimmune patients specialist care within one to two weeks, then works alongside you, with clear notes back after every clinical change.
- Specialist appointment within 1–2 weeks
- Simple referral, no back-and-forth
- Continuous monitoring between specialist visits
- Evidence-based lifestyle support, clinician-supervised
- Shared care: you stay their primary physician, fully in the loop
Time to see a rheumatologist
For health plans
Lower costs by
catching flares early
Inflammatory arthritis is one of the costliest chronic conditions a plan manages, and spend concentrates where control is lost: flares, emergency visits, hospital stays. Cressa closes the gap between specialist appointments with continuous monitoring and a care team that acts early, designed to keep more members in remission and out of acute care.
Average annual direct medical cost per rheumatoid arthritis patient on biologic therapy1
Average wait for a new rheumatology appointment, the longest of any specialty surveyed2
In remission
High disease activity
Bring Cressa to your members
Remote therapeutic monitoring is reimbursable under Medicare and many commercial plans.
- 1. Hresko A, et al. Medical care costs associated with rheumatoid arthritis in the US: a systematic literature review and meta-analysis. Arthritis Care & Research, 2018.
- 2. AMN Healthcare / Merritt Hawkins. The Waiting Game: New-Patient Appointment Access for US Physicians. Average across 23 US metro areas.
- 3. Curtis JR, et al. The clinical and economic costs of not achieving remission in rheumatoid arthritis. Arthritis & Rheumatology 2015;67(suppl 10). Medicare-linked registry data; crude rates, high disease activity vs remission.